|
1
|
Gukovskaya AS and Pandol SJ: Cell death
pathways in pancreatitis and pancreatic cancer. Pancreatology.
4:567–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Glinsky GV, Berezovska O and Glinskii AB:
Microarray analysis identifies a death-from-cancer signature
predicting therapy failure in patients with multiple types of
cancer. J Clin Invest. 115:1503–1521. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Glinsky GV: ‘Stemness’ genomics law
governs clinical behavior of human cancer: implications for
decision making in disease management. J Clin Oncol. 26:2846–2853.
2008.
|
|
4
|
Atanassov BS, Evrard YA, Multani AS, et
al: Gcn5 and SAGA regulate shelterin protein turnover and telomere
maintenance. Mol Cell. 35:352–364. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang XY, Varthi M, Sykes SM, et al: The
putative cancer stem cell marker USP22 is a subunit of the human
SAGA complex required for activated transcription and cell-cycle
progression. Mol Cell. 29:102–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Lang G, Ito S, et al: A TFTC/STAGA
module mediates histone H2A and H2B deubiquitination, coactivates
nuclear receptors, and counteracts heterochromatin silencing. Mol
Cell. 29:92–101. 2008. View Article : Google Scholar
|
|
7
|
Lee HJ, Kim MS, Shin JM, Park TJ, Chung HM
and Baek KH: The expression patterns of deubiquitinating enzymes,
USP22 and Usp22. Gene Expr Patterns. 6:277–284. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu YL, Yang YM, Xu H and Dong XS:
Increased expression of ubiquitin-specific protease 22 can promote
cancer progression and predict therapy failure in human colorectal
cancer. J Gastroenterol Hepatol. 25:1800–1805. 2010. View Article : Google Scholar
|
|
9
|
Liu YL, Yang YM, Xu H and Dong XS:
Aberrant expression of USP22 is associated with liver metastasis
and poor prognosis of colorectal cancer. J Surg Oncol. 103:283–289.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang DD, Cui BB, Sun LY, et al: The
co-expression of USP22 and BMI-1 may promote cancer progression and
predict therapy failure in gastric carcinoma. Cell Biochem Biophys.
61:703–710. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Yao L, Zhang X, et al: Elevated
expression of USP22 in correlation with poor prognosis in patients
with invasive breast cancer. J Cancer Res Clin Oncol.
137:1245–1253. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lv L, Xiao XY, Gu ZH, Zeng FQ, Huang LQ
and Jiang GS: Silencing USP22 by asymmetric structure of
interfering RNA inhibits proliferation and induces cell cycle
arrest in bladder cancer cells. Mol Cell Biochem. 346:11–21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ning J, Zhang J, Liu W, Lang Y, Xue Y and
Xu S: Overexpression of ubiquitin-specific protease 22 predicts
poor survival in patients with early-stage non-small cell lung
cancer. Eur J Histochem. 56:e462012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ling SB, Sun DG, Tang B, et al: Knock-down
of USP22 by small interfering RNA interference inhibits HepG2 cell
proliferation and induces cell cycle arrest. Cell Mol Biol.
58(Suppl): OL1803–OL1808. 2012.PubMed/NCBI
|
|
15
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ogier-Denis E and Codogno P: Autophagy: a
barrier or an adaptive response to cancer. Biochim Biophys Acta.
1603:113–128. 2003.PubMed/NCBI
|
|
17
|
Pattingre S, Bauvy C and Codogno P: Amino
acids interfere with the ERK1/2-dependent control of macroautophagy
by controlling the activation of Raf-1 in human colon cancer HT-29
cells. J Biol Chem. 278:16667–16674. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pardo R, Lo Ré A, Archange C, et al:
Gemcitabine induces the VMP1-mediated autophagy pathway to promote
apoptotic death in human pancreatic cancer cells. Pancreatology.
10:19–26. 2010. View Article : Google Scholar
|
|
19
|
Tung WL and Wang Y, Gout PW, Liu DM,
Gleave M and Wang Y: Use of irinotecan for treatment of small cell
carcinoma of the prostate. Prostate. 71:675–681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
21
|
Debnath J, Baehrecke EH and Kroemer G:
Does autophagy contribute to cell death? Autophagy. 1:66–74. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Hou N, Faried A, Tsutsumi S and
Kuwano H: Inhibition of autophagy augments 5-fluorouracil
chemotherapy in human colon cancer in vitro and in vivo model. Eur
J Cancer. 46:1900–1909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu F, Liu D, Yang Y and Zhao S: Effect of
autophagy inhibition on chemotherapy-induced apoptosis in A549 lung
cancer cells. Oncol Lett. 5:1261–1265. 2013.PubMed/NCBI
|
|
24
|
Shingu T, Fujiwara K, Bögler O, et al:
Inhibition of autophagy at a late stage enhances imatinib-induced
cytotoxicity in human malignant glioma cells. Int J Cancer.
124:1060–1071. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujii S, Mitsunaga S, Yamazaki M, et al:
Autophagy is activated in pancreatic cancer cells and correlates
with poor patient outcome. Cancer Sci. 99:1813–1819.
2008.PubMed/NCBI
|
|
26
|
Yang S and Kimmelman AC: A critical role
for autophagy in pancreatic cancer. Autophagy. 7:912–913. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang S, Wang X, Contino G, et al:
Pancreatic cancers require autophagy for tumor growth. Genes Dev.
25:717–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rausch V, Liu L, Apel A, et al: Autophagy
mediates survival of pancreatic tumour-initiating cells in a
hypoxic microenvironment. J Pathol. 227:325–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egner JR: AJCC cancer staging manual.
JAMA. 304:1726–1727. 2010. View Article : Google Scholar
|
|
30
|
Gillett CE: Immunohistochemistry. Methods
Mol Med. 120:191–200. 2006.
|
|
31
|
Cherra SR III, Kulich SM, Uechi G, et al:
Regulation of the autophagy protein LC3 by phosphorylation. J Cell
Biol. 190:533–539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang H, Cheng D, Liu W, Peng J and Feng
J: Protein kinase C inhibits autophagy and phosphorylates LC3.
Biochem Biophys Res Commun. 395:471–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levine B and Klionsky DJ: Development by
self-digestion: molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guerra C, Collado M, Navas C, et al:
Pancreatitis-induced inflammation contributes to pancreatic cancer
by inhibiting oncogene-induced senescence. Cancer Cell. 19:728–739.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neesse A, Michl P, Frese KK, et al:
Stromal biology and therapy in pancreatic cancer. Gut. 60:861–868.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Burris HR, Moore MJ, Andersen J, et al:
Improvements in survival and clinical benefit with gemcitabine as
first-line therapy for patients with advanced pancreas cancer: a
randomized trial. J Clin Oncol. 15:2403–2413. 1997.PubMed/NCBI
|
|
37
|
Donadelli M, Dando I, Zaniboni T, et al:
Gemcitabine/cannabinoid combination triggers autophagy in
pancreatic cancer cells through a ROS-mediated mechanism. Cell
Death Dis. 2:e1522011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
DeNicola GM, Karreth FA, Humpton TJ, et
al: Oncogene-induced Nrf2 transcription promotes ROS detoxification
and tumorigenesis. Nature. 475:106–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
